- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GEOPHARMA Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 62,80 | -0,76 % | Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market | ||
| CSPC PHARMA | 1,023 | +0,79 % | BofAS Lowers TP for CSPC Pharmaceutical to HKD7.4, Raises Gross Margin Forecast, Reiterates 'Buy' | ||
| SELLAS LIFE SCIENCES | 3,465 | -0,86 % | SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 | ||
| CATALYST PHARMACEUTICALS | 20,480 | -1,30 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance | Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total Revenues Q4 2025 Total Revenues of $152.6 Million, Fueled by 18.3%... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 18,370 | -0,14 % | Acadia Pharma upgraded at BofA following stock pullback | ||
| MADRIGAL PHARMACEUTICALS | 438,90 | +0,21 % | Madrigal Pharmaceuticals-Aktie +12%: Kommt's zur Übernahme? | Die Aktie des US-Pharmaunternehmens Madrigal Pharmaceuticals hat einen kräftigen Kurssprung verzeichnet, nachdem Spekulationen über eine mögliche Übernahme durch den Pharmariesen Eli Lilly aufkamen.... ► Artikel lesen | |
| OPUS GENETICS | 3,790 | -0,39 % | Opus Genetics, Inc.: Opus Genetics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026 | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - February 17, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| SAVARA | 4,380 | 0,00 % | Savara Inc.: Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) | -- EMA Review of MOLBREEVI MAA Has Now Initiated, Decision Expected in Q1 2027 -- -- MOLBREEVI Biologics License Application (BLA) is Currently Under Priority Review with the U.S. Food and Drug... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 2,360 | -4,84 % | Galectin Therapeutics Inc.: Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D. | NORCROSS, Ga., March 17, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 0,610 | 0,00 % | Biodexa Pharmaceuticals PLC: Preliminary Results for the Year Ended 31 December 2025 | March 27, 2026 Biodexa Pharmaceuticals PLC("Biodexa" or the "Company" or, together with its subsidiaries, the "Group") Preliminary Results for the Year Ended 31 December 2025 Biodexa Pharmaceuticals... ► Artikel lesen | |
| NOVABAY PHARMACEUTICALS | 1,370 | -6,80 % | NovaBay Pharmaceuticals, Inc.: NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update | Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 11,400 | +14,00 % | Cipher Pharmaceuticals übertrifft Gewinnerwartungen, verfehlt aber Umsatzziel | ||
| NEURIZON THERAPEUTICS | 0,040 | -6,98 % | NEURIZON THERAPEUTICS LIMITED: Change of Director's Interest Notices x4 | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
GEOPHARMA INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GEOPHARMA INC finden Sie auf Wallstreet Online.